Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Innovative Immunotherapeutic Treatments
Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases.
With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Identity
| Name | Scinai Immunotherapeutics |
|---|---|
| Slug | scinai-immunotherapeutics |
| Former names | BiondVax Pharmaceuticals |
| Type / kind | startup |
| Crunchbase ID | biondvax |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6_0vsIDA |
Status
| Status | acquired |
|---|---|
| Status reason | Acquired by Pincell srl on Jun, 2025 |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Jerusalem District |
| HQ city | Jerusalem |
| HQ address | Jerusalem BioPark, Hadassah Ein Kerem Campus |
Web & social
| Website | https://www.scinai.com/ |
|---|---|
| Careers page | https://www.scinai.com/careers |
| https://www.linkedin.com/company/725313 | |
| Twitter / X | https://twitter.com/scinai_ |
| https://www.facebook.com/ScinaiSCNI | |
| YouTube | https://www.youtube.com/@Scinai |
| https://www.instagram.com/scinai.immunotherapeutics |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesHealthcareProvidersPatientsLife SciencesPharmaceuticals
Business models
B2B2CB2B
Tags
immunotherapyautoimmune-diseasespharmaceuticalsviral-diseasesbiotechnologytherapeuticsinfectious-diseasedrug-discoverytreatmentsdrug-deliverybiopharmaceuticalvaccinespatientsnanotechnology
Funding
| Total raised | $63.9M |
|---|---|
| Current stage | Public |
| Market cap | $2.3M |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}